Thesis Statement: In today's trading, Stericycle Inc (SRCL, Financial) saw a significant daily gain of 15.42%, with a modest 3-month gain of 2.48%. Despite a recent Loss Per Share of 0.22, the critical question remains: Is Stericycle fairly valued? This analysis delves into the valuation of Stericycle, encouraging investors to consider whether the current stock price reflects the company's true worth.
Company Introduction
Stericycle is a leader in medical waste disposal and data destruction in the United States, significantly outpacing competitors like Sharps Compliance and Iron Mountain in its respective fields. With a global presence and about 20% of its revenue from outside North America, Stericycle plays a crucial role in regulated waste management and compliance solutions. Currently trading at $51.65, Stericycle's market cap stands at $4.80 billion, closely aligning with the GF Value estimate of $49.33, suggesting that the stock might be fairly valued. Below is an income breakdown chart that further illustrates the financial nuances of Stericycle.
Understanding GF Value
The GF Value is a proprietary measure used to estimate the fair value of a stock. It integrates historical trading multiples, a GuruFocus adjustment factor based on past performance, and future business performance estimates. This metric suggests that Stericycle's stock price should ideally hover around this value, providing a benchmark for investors to assess whether the stock is overvalued or undervalued. Currently, the GF Value indicates that Stericycle is fairly priced, aligning closely with its market performance.
Financial Strength and Risks
Stericycle's financial strength is crucial for investors seeking stability and minimal risk of capital loss. With a cash-to-debt ratio of 0.02, Stericycle's ability to cover its debts is less robust compared to its peers, ranking lower than 92.83% of companies in the Waste Management industry. This positions Stericycle in a precarious financial situation that potential investors should consider carefully.
Profitability and Growth Prospects
Despite its industry leadership, Stericycle has encountered challenges in maintaining high profitability and growth. With a 5-year average profitability rank of 4 out of 10, its performance has been relatively weak. The company's revenue growth rate over the past three years was -0.5%, indicating a slight contraction. This aspect could be a concern for investors looking for growth in addition to stability.
ROIC vs. WACC: A Measure of Value Creation
Comparing the Return on Invested Capital (ROIC) and the Weighted Average Cost of Capital (WACC) provides insight into how effectively Stericycle is generating returns on its investments. Currently, Stericycle's ROIC of -13.29% is significantly below its WACC of 8%, indicating that the company is not creating value for its shareholders, which could be a red flag for potential investors.
Conclusion
In conclusion, while Stericycle (SRCL, Financial) appears to be fairly valued based on the GF Value, its financial strength, profitability, and value creation metrics suggest a cautious approach for potential investors. For those interested in exploring further, detailed financials of Stericycle can be found here.
To discover high-quality companies that may deliver above-average returns with reduced risk, consider using the GuruFocus High Quality Low Capex Screener.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
